Frank A. Vicini MD FASTRO
National Director, Research and Breast Care Services
Join to View Full Profile
70 Fulton StPontiac, MI 48341
Phone+1 248-338-0300
Fax+1 248-338-0663
Dr. Vicini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Frank Vicini is a Radiation Oncologist based in Pontiac, MI with an extensive career in clinical practice, academia and research. He completed his medical education at Wayne State University School of Medicine, his residency in Radiation Oncology at Corewell Health East Beaumont and a fellowship in breast cancer at Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School. Dr. Vicini serves as a Program Director at the MHP Radiation Oncology Institute and has been a long-standing physician at Corewell Health Farmington Hills Hospital since 1989. He has published numerous research papers on breast cancer treatment and has been involved in significant clinical trials for breast cancer therapies. He has been recognized in various years by Castle Connolly as one of America's Top Doctors and Top Doctors for Cancer, and has also received certification from MOSAIQ EMR, Elekta.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1989 - 1990
Corewell Health William Beaumont University HospitalResidency, Radiation Oncology, 1986 - 1989- Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1985 - 1986
Wayne State University School of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1987 - 2028
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
- Join now to see all
Clinical Trials
- 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection Start of enrollment: 2003 Aug 01
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery Start of enrollment: 2011 May 24
Publications & Presentations
PubMed
- CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High Risk.Chirag Shah, Frank A Vicini, Eileen P Connolly, Rachel A Rabinovitch, Brian Czerniecki
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 1 citationsA 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conser...Frank Vicini, Chirag Shah, Karuna Mittal, Jame Abraham, Megan Kruse
Clinical Breast Cancer. 2025-02-01 - 1 citationsQuality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery.Patricia A Ganz, Reena S Cecchini, Julia R White, Frank A Vicini, Douglas W Arthur
Journal of the National Cancer Institute. 2025-01-01
Journal Articles
- Targeted Intraoperative Radiotherapy for Early Breast CancerDavid Wazer, Frank Vicini, JAMA Oncology
Other
- Efficacy, Improved Quality of Life, and Cost-Effectiveness of Partial Breast IrradiationFrank Vicini, MD, JAMA Oncology
https://www.doximity.com/articles/306c7e99-6a6d-4c3d-9de8-7f6e06c3b102
UpToDate, Wolters Kluwer Health - 2012-11-21
Press Mentions
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS PatientsOctober 2nd, 2024- Whole Breast Radiation for Breast Cancer Shown to Be Safe and EffectiveDecember 1st, 2022
- Early-Stage Breast Cancer: 3 Weeks of Radiation May Be Just as Effective as 6November 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
